Peter Yan – CEO, Cyberport
Cyberport brands itself as Hong Kong’s digital technology hub and today plays host to roughly 2,000 start-ups and technology companies. CEO Peter Yan outlines how Cyberport is helping develop its…
MediConcepts was founded with the aim to provide the optimized solutions for medical device design development and manufacturing to a wide range of customers whether they are innovators who need a compliant product development process and collaboration; or projects seeking for a reliable high quality mass production with complete traceability.
Early projects that MediConcepts encountered include redeveloping a two hand operated intra-ocular lens disposable case to an one hand operated casing in late 90’s; and a minimal invasive tissue retrieval system originated from a UK surgeon who is also a pioneer in minimal access surgery in early 2000’s. The design briefs were simply a hand-sketched drawing faxed to us and we delivered a complete design and production in less than 6 months. Since then, our philosophy has been focusing on “design by surgeon for surgeons” medical devices.
The range of products that we now cover are very broad. “Think Medical” is our believe and “Redefine the medical device Contract Manufacturing Experience” is what we want to offer to our customers. Eventually, we want to position MC to be the ideal CM.
Contact
Address 7A-D Hong Kong Industrial Building, 444-452 Des Voeux Road West, Hong Kong
Tel: +852 2838 0300
Website: http://www.mediconcepts.com/
Email: marketing@mediconcepts.com
Cyberport brands itself as Hong Kong’s digital technology hub and today plays host to roughly 2,000 start-ups and technology companies. CEO Peter Yan outlines how Cyberport is helping develop its…
Commonly regarded ‘the father of Hong Kong biotechnology’, Professor Lo Yuk Lam has had a hand in almost all of the city’s biotech success stories, including those of Michael Yang…
Well established as Asia’s leading financial services and trading hub, Hong Kong is now looking to better position itself as a centre for biotechnology investment and start-ups. However, in a…
As managing director of the CR-CP Life Science Fund, whose shareholders, CR Group and CP Group, are on the Fortune Global 500 List, Da Liu leads investments in life sciences…
Tech entrepreneur and investor Duncan Chiu has long been committed to developing local technology and innovation in Hong Kong. He discusses the current blueprint for advancing life sciences, advanced manufacturing,…
A groundbreaking research scientist noted for his work in non-invasive blood-based diagnoses, Professor Dennis Lo currently holds a number of positions at the Chinese University of Hong Kong (CUHK). Lo, whose…
With the global market for cell and gene therapy (CGT) products set to skyrocket in the coming years, Hong Kong is looking to get in on the action with the…
Professor Michael Yang of City University of Hong Kong (CityU) introduces the ‘HK Tech 300‘ programme he oversees, the largest university-based entrepreneurship programme in Asia. Drawing on his own experience…
Hong Kong’s Secretary for Innovation, Technology and Industry since July 2022, Professor Dong SUN is a pioneer in robotic manipulation of biological cells and robot control, whose research has led…
Former chief executive of the Hong Kong Special Administrative Region (HKSAR) Leung Chun-ying (CY Leung) discusses recent science and technology initiatives like the new Hong Kong University of Science and…
In 2022, the biotech sector felt the impact of the challenges facing global capital markets and Hong Kong was no exception. Last year, only eight biotech companies listed on the…
After a record year of new biotech listings in 2021, the Hong Kong Stock Exchange (HKEX) has seen a significant drop-off in the first eight months of 2022. The exchange…
See our Cookie Privacy Policy Here